when does tirzepatide patent expire expiry expiration eli lilly Tirzepatide's primary patents in 2036 but Eli Lilly has In weight loss battle, Novo

Tirzepatide is available as the brand-name medicines Zepbound and Mounjaro (which is FDA-approved for Type 2 diabetes management)

Weight loss was similarly enhanced, with tirzepatide 15 mg producing a mean reduction of 11.2 kg compared to 5.7 kg with semaglutide

Alcohol also affects blood sugar regulation and can increase dehydration, which may worsen medication-related dizziness or fatigue

The most commonly reported adverse effects were gastrointestinal in nature , including: Nausea Vomiting Diarrhoea Constipation Decreased appetite These effects were generally mild to moderate in severity, most prevalent during dose escalation, and tended to diminish over time